TransCode Therapeutics, Inc.

RNAZ · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$2,835,916$7,375$11,569$5,811
Short-Term Investments$0$0$0$0
Receivables$0$176$322$0
Inventory$0$0$0$0
Other Curr. Assets$1,915,132$298$681$517
Total Curr. Assets$4,751,048$8,242$13,044$7,093
Property Plant & Equip (Net)$19,908$25$38$89
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$455,726$0$112$112
Total NC Assets$475,634$25$150$201
Other Assets$0$0$0$0
Total Assets$5,226,682$8,266$13,194$7,294
Liabilities
Payables$0$1,363$2,428$2,576
Short-Term Debt$0$0$0$38
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,967,828-$1,363-$2,428$26
Total Curr. Liab.$2,967,828$1,565$2,510$2,772
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$832,875$554$392$6,541
Total NC Liab.$832,875$554$392$6,541
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$3,800,703$2,119$2,902$9,313
Equity
Pref Stock$0$0$0$0
Common Stock$84$0$2$0
Retained Earnings-$84,419,882-$79,564-$75,287-$63,202
AOCI$0$0$0$0
Other Equity$85,845,777$0$0$0
Total Equity$1,425,979$6,148$10,293-$2,019
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$5,226,682$8,266$13,194$7,294
Net Debt-$2,835,916-$7,375-$11,569-$5,773